#biocryst search results
#Biocryst is t nieuwe speeltje.
#BioCryst to Announce Fourth Quarter and Full Year 2017 #FinancialResults on February 27 — CheckOrphan ow.ly/HClw30ivCTE @RareDiseases @raredisorders @eurordis
Will BioCryst's ORLADEYO Hit The $1 Billion Sales Mark? dlvr.it/TQlkWq #BioCryst #ORLADEYO #Pharmaceuticals #BCRX #HereditaryAngioedema
Key Date Approaching for $BCRX Shareholders #BioCryst crweworld.com/symbol/BCRX
BioCryst to Acquire Astria Therapeutics $BCRX, #BioCrystPharma, #BioCryst, $ATXS, #AstriaTherapeutics, #AstriaTx, #Astria crweworld.com/article/news-p…
#BioCryst Announces Initiation of the APeX-S Long-Term Safety #Trial in Patients with Hereditary #Angioedema — CheckOrphan ow.ly/ZS5b30iGMtM @RareDiseases @raredisorders @Rare @RareConnect @rarediseasesnet
After #BioCryst fizzle, a new oral #HAE player emerges endpts.com/after-biocryst…
Although @BioCrystPharma probably wanted to tout the success of its Orladeyo launch in its financial report, it was overshadowed by news that the @US_FDA placed a partial clinical hold on three of its clinical trials. #BioCryst #Orladeyo #FDA #BioSpace hubs.li/Q019CHKq0
NIAID Awards $BCRX New $44M Contract to Advance Development of Galidesivir #BioCryst crweworld.com/symbol/BCRX
$BCRX Reveals Berotralstat Expanded Access Program for Patients with Hereditary Angioedema in the United States #BioCryst #AngioEdema #HAE crweworld.com/symbol/BCRX
The Real Numbers Behind $BCRX Revealed #BioCryst #BioCrystPharmaceuticals crweworld.com/article/news-p…
Is #BioCryst Pharmaceuticals A Good #Biotech #Stock To Own? $BCRX talkmarkets.com/content/stocks…
$BCRX 's BCX9930 Shows Clinical Benefit as Monotherapy Through 400 mg bid in Treatment-naïve Paroxysmal Nocturnal Hemoglobinuria Patients #BioCryst #PNH crweworld.com/symbol/BCRX
BioCryst Partners with Irish Affiliate of Neopharmed Gentili in ~$345M EU Commercialization Deal for Navenibart #biocryst #neopharmedgentili #navenibart #licensingdeal #hereditaryangioedema #plasmakallikreininhibitor #piii #pharma pharmashots.com/33101/biocryst…
Can Recent Catalysts Breakout #BioCryst To New Highs? $BCRX talkmarkets.com/content/stocks…
$BCRX Reveals 96-week Data from APeX-2 Trial Showing ORLADEYO Reduced HAE Attack Rate by 80% from Baseline #BioCryst #BioCrystPharmaceuticals #BCRX #HAE #HereditaryAngioEdema crweworld.com/symbol/BCRX
U.S. Government Awards BioCryst $69M RAPIVAB (peramivir injection) Contract for Strategic National Stockpile $BCRX, #BioCrystPharma, #BioCryst crweworld.com/article/news-p…
$BCRX to discontinue the pursuit of a COVID-19 indication for galidesivir #BioCryst crweworld.com/symbol/BCRX
UK's Medicines and Healthcare products Regulatory Agency Grants HAE Patients Early Access to $BCRX ’s Berotralstat #BioCryst crweworld.com/symbol/BCRX
Neopharmed Gentili to pay BioCryst $250M upfront for the European assets and rights related to ORLADEYO, and up to $14M in future milestones $BCRX, #BioCrystPharma, #BioCryst crweworld.com/article/news-p…
BioCryst Partners with Irish Affiliate of Neopharmed Gentili in ~$345M EU Commercialization Deal for Navenibart #biocryst #neopharmedgentili #navenibart #licensingdeal #hereditaryangioedema #plasmakallikreininhibitor #piii #pharma pharmashots.com/33101/biocryst…
BioCryst Pharmaceuticals to receive $70M upfront + up to $275M in milestone payments + royalties on sales for exclusive license deal to commercialize navenibart for hereditary angioedema in Europe $BCRX, #BioCrystPharma, #BioCryst crweworld.com/article/news-p…
$BCRX is seeing intense volume as M&A rumors swirl. 📈 Investors are debating valuation vs. its rare-disease franchise, eyeing a potential buyout premium. Watching pre-market action for institutional entry. 💊💰 #BioCryst #Stocks #MA
1/6 🧵 ¿Por qué todo el mundo habla de BioCryst ($BCRX) en 2026? Tras años de quemar caja, la biotecnológica ha dado un giro de 180°. De pérdidas netas a una rentabilidad que el mercado empieza a notar. Vamos con los datos. 👇 #BioCryst #Inversión #Biotech
Will BioCryst's ORLADEYO Hit The $1 Billion Sales Mark? dlvr.it/TQlkWq #BioCryst #ORLADEYO #Pharmaceuticals #BCRX #HereditaryAngioedema
BioCryst expects continued non-GAAP profitability in 2026 $BCRX, #BioCrystPharma, #BioCryst crweworld.com/article/news-p…
Exciting news from $BCRX! FDA approves ORLADEYO oral pellets for children with HAE aged 2 to <12. A significant advancement in treatment options. #BioCryst #FDA #HAE notdumbmoney.com/bcrx/202512121…
BioCryst Pharmaceuticals: FDA OKs ORLADEYO (berotralstat) Oral Pellets, First and Only Oral Prophylactic Treatment for Patients with Hereditary Angioedema (HAE) Aged 2 to <12 Years $BCRX, #BioCrystPharma, #BioCryst crweworld.com/article/news-p…
$BCRX just flipped the game for kids with HAE 😲 FDA greenlights ORLADEYO (berotralstat) oral pellets, the first EVER pill to prevent attacks in ages 2–11. This is history in the making 💊 #BioCryst #HAE #ORLADEYO #FDAApproval #PediatricCare #RareDisease #MedicalBreakthrough
Exciting news for BioCryst Pharmaceuticals $BCRX ! Early HSR waiting period termination paves the way for Astria Acquisition. 🚀 #BioCryst #Acquisition #Healthcare notdumbmoney.com/bcrx/202512031…
BioCryst Receives Early Termination of HSR Waiting Period for Astria Acquisition $BCRX, #BioCrystPharma, #BioCryst, $ATXS, #AstriaTherapeutics, #AstriaTx, #Astria crweworld.com/article/news-p…
BioCryst Pharmaceuticals, Inc. to Acquire Astria Therapeutics, Inc. in ~$700M Cash-and-Stock Transaction #biocryst #astria #navenibart #piii #alphaorbit #atopicdermatitis #star0310 #immunology #ma #qls215 #star0215 #hereditaryangioedema pharmashots.com/28724/biocryst…
BioCryst to Acquire Astria Therapeutics $BCRX, #BioCrystPharma, #BioCryst, $ATXS, #AstriaTherapeutics, #AstriaTx, #Astria crweworld.com/article/news-p…
Neopharmed Gentili to pay BioCryst $250M upfront for the European assets and rights related to ORLADEYO, and up to $14M in future milestones $BCRX, #BioCrystPharma, #BioCryst crweworld.com/article/news-p…
BioCryst: New data on the long-term efficacy and safety of ORLADEYO across pediatric, adolescent, and adult populations show sustained reductions in hereditary angioedema (HAE) attacks and consistent safety profile $BCRX, #BioCrystPharma, #BioCryst crweworld.com/article/news-p…
BioCryst Pharmaceuticals: ORLADEYO (berotralstat) approved in Colombia for the prophylaxis of hereditary angioedema (HAE) attacks in adults and pediatric patients 12 years of age or older $BCRX, #BioCrystPharma, #BioCryst crweworld.com/article/news-p…
BioCryst Pharmaceuticals: Real-world Data Show ORLADEYO (berotralstat) Consistently Reduces HAE Attacks Across All Ages $BCRX, #BioCrystPharma, #BioCryst crweworld.com/article/news-p…
BioCryst Reports the US FDA’s NDA Acceptance and Priority Review of Orladeyo for Hereditary Angioedema (HAE) #biocryst #orladeyo #berotralstat #hereditaryangioedema #piii #apexp #prophylactictherapy #aaaaiwao2025 #plasmakallikreininhibitor #nda #usfda pharmashots.com/23095/biocryst…
💫 Comienza la inauguración de la jornada de #HumanizacionRarasRM con: 👤María Celia García, directora general de Humanización, Atención y Seguridad del #Paciente de @SaludMadrid 👤Carlos Lorenzi, director general para España y Portugal de #BioCryst 👤Ricardo López, director
🗓️Así ha sido la inauguración de la jornada 'Humanización en Enfermedades Raras', organizada por Redacción Médica con la colaboración de #BioCryst ➡️ tinyurl.com/3nvkwb5k
#DeathCross $BCRX at 3.48 R55 HiLo 6% T1Y 13 buy 2.2 fwdPE -2.9 DIV N/A #BioCryst P #stocks #trading #finance #market bit.ly/2QfAnuH
@BioCrystPharma Enters into a License Agreement with @clearsidebio for the Development of Avoralstat to Treat Diabetic Macular Edema (DME) #BioCryst #Clearside #Avoralstat #Diabetic #Macular #Edema #DME #Pharma #Collaboration #SCS #Microinjector pharmashots.com/16327/biocryst…
Después de una cálida bienvenida a las regiones y un delicioso café ☕, participamos en una MasterClass sobre estrategias que nos fortalecen como líderes 💪. #AEHI #AEHCO #BioCryst #Takeda #CSLBehring #Pharming
#BioCryst announces #Mundipharma Receives Approval for Mundesine® in Japan....pharmafocusasia.com/news/mundiphar…
#TRADINGopportunity $BCRX #BIOCRYST #BIOTECH DIA VIERNES DEPOSITAMOS FOCO DE INVERSION EN EL NIVEL DE USD 4,05 FRENTE A CHANCE DE HABILITACION FIGURA TECNICA DE HCH INVERTIDO INDICADOR "FLOWS INVESTING COMPA" MOSTRARIA LA POSIBILIDAD DE AVANCE CONTRA MERCADO TARGET AREA 8,75-9
After holding #silver together, #Reddit retail investors took the lead in the biomedical sector. On Monday, the share price of #Biocryst rose to a five-year high. Professionals are also trying to profit from the current speculative mood, the agency says. #HedgeFunds #ShortSqueeze
$BCRX what a beautiful picture.....you don’t see these too often like thissssss...📈...but when you dooooooo...ohh weeeeeeee.... #BioCryst 💰
TD SELL $BCRX at 10.49, Supp 8.57 Resis 10.88 R27 HiLo 22% T1Y 17 buy 2.3 DIV N/A #BioCryst P #stocks #trading #finance #market
Will BioCryst's ORLADEYO Hit The $1 Billion Sales Mark? dlvr.it/TQlkWq #BioCryst #ORLADEYO #Pharmaceuticals #BCRX #HereditaryAngioedema
🎯$BCRX altro centro! 🚀🚀🚀🚀titolo da tenere long! Le vendite di Orladeyo faranno salire gli utili al 🔝#BioCryst #growth #Biomedical #investimento #investments #money #Nasdaq #Nyse #portfolio #StocksToBuy #WallStreet
TD BUY $BCRX at 10.17, Supp 9.72 Resis 13.48 R39 HiLo 67% T1Y 15 buy 2.0 fwdPE -13.7 DIV N/A #BioCryst P #stocks #trading #finance #market bit.ly/3wiKunm
#Biocryst Pharmaceuticals $BCRX Entré en #pivoteepisodico Catalizador: #Earnings ( extraordinarios de 3 dígitos ), #sales en aceleración QoQ y YoY El Volumen de hoy #bullsnort es el más grande desde mediados del año 2023 Ya en #Breakeven #ep #episodicpivot #Qullamaggie
#DeathCross $BCRX at 11.48 R6 HiLo 30% T1Y 18 hold 2.6 DIV N/A #BioCryst P #stocks #trading #finance #market
#GoldenCross $BCRX at 17.75 R8 HiLo 80% T1Y 20 buy DIV N/A #BioCryst P #stocks #trading #finance #market
Tom Staab, Chief Financial Officer & Treasurer #BioCryst Pharmaceuticals, was elected Chairman of #NCBIO today.
#GoldenCross $BCRX at 4.70 R32 HiLo 50% T1Y 7 buy fwdPE -6.9 DIV N/A #BioCryst P #stocks #trading #finance #market tinyurl.com/ycgpfwgc
Something went wrong.
Something went wrong.
United States Trends
- 1. RED Friday N/A
- 2. Lakers N/A
- 3. #AllStars11 N/A
- 4. Labour N/A
- 5. Starmer N/A
- 6. Bungie N/A
- 7. #BROWN N/A
- 8. Reform N/A
- 9. #DragRace N/A
- 10. Thunder N/A
- 11. Shai N/A
- 12. Confederate N/A
- 13. Sir David Attenborough N/A
- 14. Reaves N/A
- 15. QUICK TRADE N/A
- 16. Smart Money - Buy N/A
- 17. Jake Laravia N/A
- 18. Rachel Scott N/A
- 19. Whale - Buy N/A
- 20. TOP CALL N/A